Author

J. O. Blakeley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:database / resource· 1

Frequent Co-Authors

C. A. Pratilas· 2 shared A. Belzberg· 1 shared A. C. Bakker· 1 shared A. K. Meeker· 1 shared B. Slobogean· 1 shared C. Davis· 1 shared C. G. Eberhart· 1 shared C. M. Heaphy· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. A. Pratilas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Therapeutic vulnerability to ATR inhibition in concurrent NF1 and ATRX-deficient high-grade solid tumors

M. Yuan, C. G. Eberhart, C. A. Pratilas, J. O. Blakeley, C. Davis, M. Stojanova, K. Reilly, A. K. Meeker, C. M. Heaphy, F. J. Rodriguez

This study shows that combining NF1 and ATRX deficiency makes certain solid tumors vulnerable to ATR inhibition, especially those with alternative lengthening of telomeres.

bioRxiv · Feb 3, 2022 · PreprintCancer Biology

A clinically and genomically annotated nerve sheath tumor biospecimen repository.

K. Pollard, J. Banerjee, X. Doan, J. Wang, X. Guo, R. J. Allaway, S. Langmead, B. Slobogean, C. Meyer, D. Loeb, C. Morris, A. Belzberg, J. O. Blakeley, F. Rodriguez, J. Guinney, , C. A. Pratilas

The paper establishes a clinically and genomically annotated nerve sheath tumor biospecimen repository to support research on NF1-related tumors.

bioRxiv · Dec 19, 2019Cancer Biology

Delivering on the Vision of Bench to Bedside: A Rare Disease Funding Community Collaboration to Develop Effective Therapies for Neurofibromatosis Type 1 Tumors

S. La Rosa, V. Browder, A. C. Bakker, J. O. Blakeley, S. K. Verma, L. M. Wong, J. A. Morris, N. Bora

The paper analyzes funding efforts by four organizations to accelerate MEK inhibitor development for NF1-associated tumors.

bioRxiv · Feb 19, 2019Scientific Communication & Education